Pertuzumab: as a tool
4 studies: an imaging tracer or a test of drug response. Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?CompletedNCT02286843Not applicableResults postedReport a problem
- Testing a New Imaging Agent to Identify CancerActive, not recruitingNCT04692831Phase 1Report a problem
- Imaging With a New Agent That Finds a Cancer Protein Called HER2CompletedNCT03109977Phase 1Report a problem
- Imaging With 111 Indium (111In)-Pertuzumab (PmAb) to Predict Response to Trastuzumab (TmAb) in Human Epidermal Growth Factor-2 (HER2) Positive Metastatic Breast Cancer (MBC) or Locally Advanced Breast Cancer (LABC)TerminatedNCT01805908Phase 1Report a problem